Regents of the University of California Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intellia Therapeutics
NTLA
|
+$12.1M |
| 2 |
XYZ
Block Inc
XYZ
|
+$3.79M |
| 3 |
Trip.com Group
TCOM
|
+$2.14M |
| 4 |
Okta
OKTA
|
+$1.68M |
| 5 |
TRTN
Triton International Limited
TRTN
|
+$740K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.44% |
| 2 | Technology | 9.3% |
| 3 | Consumer Staples | 7.65% |
| 4 | Energy | 4.24% |
| 5 | Financials | 3.82% |
Similar funds
Regents of the University of California's Q4 2017 Portfolio in Review
As of Q4 2017, Regents of the University of California held 27 positions worth $66.3M, up 38% from $48M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Regents of the University of California deployed $20M of net new capital in Q4 2017, opening 7 new positions. Its largest new stake was Intellia Therapeutics: 524,423 shares worth $10.1M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 5% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the most notable exit was Diamondback Energy, an estimated $1.41M sold.
- Regents of the University of California's largest Q4 2017 buy was Intellia Therapeutics: 524,423 shares worth $10.1M.
- Regents of the University of California fully exited Diamondback Energy in Q4 2017, selling an estimated $1.41M.
- Regents of the University of California's ten largest holdings make up 84% of its $66.3M portfolio in Q4 2017.
- Regents of the University of California opened 7 new positions and closed 1 in Q4 2017.
- Regents of the University of California's portfolio value rose 38% quarter-over-quarter to $66.3M.
Based on Regents of the University of California's 13F filing for Q4 2017, filed 13 Feb 2018.